Jeffrey Quick will cease to be the interim Chief Executive Officer of the Company on that date.
Departed
Edwin Artuz
Chief Administrative Officer
Federal Home Loan Bank of New York
Effective
2024-07-01
Filed
August 12, 2024, 7:59 PM ET
Mr. Edwin Artuz, Chief Administrative Officer, Director of Diversity & Inclusion, and Senior Vice President of the Bank, would no longer be working at the Bank effective as of the close of business on July 1, 2024.
Effective as of the date of the Agreement, Jason Cohenour and Phu Hoang have agreed not to stand for re-election at the 2024 Annual Meeting in order to ensure the Company’s compliance with the Agreement.
Effective as of the date of the Agreement, Jason Cohenour and Phu Hoang have agreed not to stand for re-election at the 2024 Annual Meeting in order to ensure the Company’s compliance with the Agreement.
As of August 8, 2024, Bakur Kalichava, the President, Treasurer, Director and Secretary of ANKAM INC. (the “Company”), is no longer holding the positions.
On August 7, 2024, Peter Wilver resigned from the board of directors (the “Board”) of Shoals Technologies Group, Inc. (the “Company”), effective as of August 9, 2024.
Departed
Paul W. Taylor
Director
HEARTLAND FINANCIAL USA INC
Effective
2024-08-07
Filed
August 9, 2024, 7:59 PM ET
On August 9, 2024, Heartland Financial USA, Inc. (the “Company”) announced that Paul W. Taylor resigned from the Company’s Board of Directors effective August 7, 2024.
Departed
Steen Karsbo
Director
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
Departed
Vyomesh Joshi
Director
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
Departed
Philippe Morali
Director
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
Departed
Dan Eaton
Chief Legal Officer
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
Company terminated all of its remaining employees and executive officers, including Uzi Sasson, its President and Chief Executive Officer, and Dan Eaton, its Chief Legal Officer
Departed
Uzi Sasson
President and Chief Executive Officer
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
Company terminated all of its remaining employees and executive officers, including Uzi Sasson, its President and Chief Executive Officer, and Dan Eaton, its Chief Legal Officer
Departed
John R. Harding
Director
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
Departed
Kenneth Hannah
Director
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
Departed
Allison Christilaw
Director
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
Departed
Peder K. Jensen
Director
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed
Kerry Clem
Chief Commercial Officer
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed
Thomas Burns
Director
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed
Sandra Panem
Director
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed
John P. Kelley
Director
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed
Neil S. Belloff
General Counsel and Corporate Secretary
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed
Ron Cohen
Chief Executive Officer
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed
Michael A. Gesser
Chief Financial Officer and Treasurer
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed
John Varian
Director
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
On August 8, 2024, Todd Magazine stepped down from his role as Chief Executive Officer of AirSculpt Technologies, Inc. (the “Company”), effective as of August 8, 2024.
In connection with stepping down from his role as Chief Executive Officer of the Company, Mr. Magazine resigned from his position as a member of the board of directors of the Company (the “Board”), effective as of August 8, 2024.
on August 7, 2024, each of Mitchell Hollin and Michele Logan delivered notice of their resignation as a member of the Board and all committees thereof, subject to and contingent on the consummation of the Closing, pursuant to the terms of the Letter Agreement.
on August 7, 2024, each of Mitchell Hollin and Michele Logan delivered notice of their resignation as a member of the Board and all committees thereof, subject to and contingent on the consummation of the Closing, pursuant to the terms of the Letter Agreement.
Departed
James Fairweather
Executive Vice President and Chief Innovation Officer
Mawson Infrastructure Group Inc. (the “Company”) announces the departure of Mr. Craig Hibbard as the Company’s Chief Development Officer given personal reasons.
Departed
Michael C. Morgan
Class I Director
Sunnova Energy International Inc.
Effective
2024-10-07
Filed
August 9, 2024, 7:59 PM ET
On August 8, 2024, Michael C. Morgan notified the Company of his resignation as a Class I director of the Board of Directors of the Company and member of the Compensation and Human Capital Committee effective October 7, 2024.
On August 5, 2024, the Board of Directors (the “Board”) of Future FinTech Group, Inc. (the “Company”) received a resignation letter from Mr. Shanchun Huang to resign from his positions as a director of the Board and the Chief Executive Officer (“CEO”) and President of the Company, effective on August 5, 2024.
On August 9, 2024, Pinterest, Inc. (the “Company”) announced that Sabrina Ellis, the Company’s Chief Product Officer would, effective immediately, transition to an advisory role and then transition from the Company to pursue other career opportunities, effective as of September 21, 2024.
On August 5, 2024, Irina Pestrikova notified ENDRA Life Sciences Inc. (“ENDRA” or the “Company”) of her resignation as the Company’s Senior Director, Finance, effective August 7, 2024.
On August 8, 2024, Michael C. Morgan notified the Board of Directors (the “Board”) and the Corporate Secretary of Stem, Inc. (the “Company”) of his resignation from the Board effective October 7, 2024 for personal reasons.
On August 5, the Company notified Jeremy Bezdek, EVP Corporate Development, that his employment with the Company would terminate, effective August 8, 2024
On August 7, 2024, Anthony Clark notified NorthWestern Energy Group, Inc. d/b/a NorthWestern Energy (Nasdaq: NWE) (the “ Company ”) of his intent to resign as a member of the Company's Board of Directors (the “ Board ”) effective December 31, 2024.
Departed
Curtis J. Dobler
Executive Vice President and Chief Human Resources Officer
On August 5, 2024, David L. Gamsey notified the Company of his intent to retire from his position as Executive Vice President and Chief Financial Officer, effective November 8, 2024.
Departed
Ronald B. Kalich
Director
SURMODICS INC
Effective
2024-08-04
Filed
August 8, 2024, 7:59 PM ET
On August 4, 2024, Ronald B. Kalich resigned from the Board of Directors of Surmodics, Inc. (the “Company”). Mr. Kalich stated that he was resigning for health reasons.
Effective August 14, 2024, upon Ms. Leone Patterson ceasing to be the Chief Financial and Business Officer, Principal Financial Officer (PFO) and Principal Accounting Officer (PAO) for Tenaya
On August 6, 2024, Terry J. Schadeberg, President, Americas, of Columbus McKinnon Corporation (the “Company”) notified the Company that he plans to retire from the Company effective September 20, 2024.
Effective as of August 7, 2024, Mr. van Hoek resigned from the Board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.